Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
4
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
4
×
amgen
biotech
deals
eli lilly
fda
investing
new york blog main
new york top stories
roche
sanofi
alder biopharmaceuticals
avapritinib
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cancer
cancer drugs
cholesterol
chronic migraine
cobimetinib
cstone pharmaceuticals
data
david rind
detroit blog main
detroit top stories
episodic migraine
eptinezumab
erenumab
european medicines agency
fisogatinib
What
drug
4
×
medicines
4
×
approval
cancer
fda
aces
amgen
announced
big
blueprint
candidate
candidates
ceo
cholesterol
class
currently
despite
developed
family
flexible
gets
hardest
head
hit
hottest
hunters
inclisiran
ipo
key
lowering
marketing
meant
medco
medicine
migraine
muscle
nasdaq
new
nod
open
Language
unset
Current search:
medicines
×
" clinical trials "
×
" san francisco top stories "
×
drug
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines